Kathryn Jean Boor - 05 Dec 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Kathryn Boor
Issuer symbol
SRPT
Transactions as of
05 Dec 2024
Net transactions value
-$205,400
Form type
4
Filing time
06 Dec 2024, 20:00:04 UTC
Previous filing
03 May 2024
Next filing
11 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Sale $205,400 -1,636 -22% $125.55 5,880 05 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.